IMA is loading

Main Financial Data 2001

Main Data: 31/12 Year 2001
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 336.30
– gross margin 156.80
– total operating cost 107.41
– net operating profit 44.87
– financial expenses, net 6.49
– net income before taxes 20.45

 

Consolidated balance sheet Millions/Euro
– operating capital 87.59
– fixed assets, net 113.28
– reserves and MLT non financial payables – 26.22
– net financial position – 75.14
– stockholders’ equity 99.51

 

Other information Millions/Euro
– depreciation 14.43
– R & D expenses 18.81

 

  Euro
Dividend per share 0.36

 

  No.
Employees 2,232

 

  Euro
Shares outstanding 18,772,000

 

Main Data: 30/06 Year 2001
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 125.42
– gross margin 57.23
– total operating cost 53.99
– net operating profit 3.24
– financial expenses, net 3.07
– net income before taxes – 0.33

 

Consolidated balance sheet Millions/Euro
– operating capital 93.40
– fixed assets, net 108.93
– reserves and MLT non financial payables – 24.37
– net financial position – 99.00
– stockholders’ equity 78.95

 

Other information Millions/Euro
– depreciation 6.71
– R & D expenses 10.42

 

  No.
Employees 2,209

 

  Euro
Shares outstanding 18,772,000

 

Net Sales by Sector: Year 2001
  Millions/Euro  
tea, herbs & coffee 49.60 14.75%
pharmaceuticals packaging 185.30 55.10%
pharmaceuticals processing 101.40 30.15%
Total 336.30 100.00%

 

Net Sales by Country: Year 2001
  Millions/Euro  
E.U. (excluding Italy) 127.88 38.03%
Other European countries 31.02 9.22%
North America 63.54 18.89%
Asia & Middle East 53.93 16.04%
Other countries 44.09 13.11%
Total exports 320.46 95.29%
Italy 15.84 4.71%
Total 336.30 100.00%
Dismissclose

Relive
Achema

The exclusive tech videos shot during Achema 2024 are now available on our dedicated website